Endo International Ordinary Shares reported $158.55M in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amarin AMRN:US $ -64.8M 36.45M
Coherus Biosciences CHRS:US $ -50.15M 45.93M
Endo International Ordinary Shares ENDP:US $ 158.55M 64.81M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Lannett LCI:US $ -22.31M 0.82M
Novartis NOVN:VX SF 4129M 217M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 11.32M 3.4M
Takeda 4502:JP Y 155473M 209520M
Teva Pharmaceutical TEVA:IT -1160000000 189M
Xeris Pharmaceuticals Inc XERS:US $ -34122000 16.67M